statistiche ricercatore

Continente	#
NA - Nord America	583
EU - Europa	477
AS - Asia	312
SA - Sud America	44
AF - Africa	20
Continente sconosciuto - Info sul continente non disponibili	14
Totale	1.450

Nazione	#
US - Stati Uniti d'America	565
IT - Italia	265
SG - Singapore	118
VN - Vietnam	55
DE - Germania	49
CN - Cina	47
BR - Brasile	39
IE - Irlanda	39
BD - Bangladesh	26
HK - Hong Kong	23
RU - Federazione Russa	20
FR - Francia	19
IN - India	16
ZA - Sudafrica	16
FI - Finlandia	14
GB - Regno Unito	14
NL - Olanda	13
SE - Svezia	13
AT - Austria	11
CA - Canada	9
KR - Corea	5
BE - Belgio	4
ES - Italia	4
ID - Indonesia	4
JP - Giappone	4
MX - Messico	3
CI - Costa d'Avorio	2
GT - Guatemala	2
JO - Giordania	2
LT - Lituania	2
PH - Filippine	2
PK - Pakistan	2
PS - Palestinian Territory	2
VE - Venezuela	2
A1 - Anonimo	1
AR - Argentina	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
BS - Bahamas	1
CH - Svizzera	1
CW - ???statistics.table.value.countryCode.CW???	1
EC - Ecuador	1
GF - Guiana Francese	1
GP - Guadalupe	1
GR - Grecia	1
HR - Croazia	1
IQ - Iraq	1
IR - Iran	1
MD - Moldavia	1
NO - Norvegia	1
PA - Panama	1
PL - Polonia	1
RO - Romania	1
RS - Serbia	1
SC - Seychelles	1
TN - Tunisia	1
TR - Turchia	1
TT - Trinidad e Tobago	1
TW - Taiwan	1
UA - Ucraina	1
UZ - Uzbekistan	1
Totale	1.438

Nome	#
Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph–Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice	288
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line	270
NEW EPH ANTAGONISTS DISCRIMINATING BETWEEN EPH-AS AND EPH-BS CLASSES	188
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids	179
Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity	166
PHARMACOLOGICAL CHARACTERIZATION OF NEW COMPOUNDS AIMED AT INHIBITING EPH-EPHRIN INTERACTION IN GLIOBLASTOMA	159
Design and synthesis of new PPI inhibitors of the EphA2 receptor targeting Glioblastoma Multiforme (GBM)	105
Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication	95
Totale	1.450

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	45	0	0	0	0	0	0	3	12	19	5	1	5
2022/2023	173	6	10	9	11	31	16	12	9	45	9	9	6
2023/2024	89	8	3	11	3	12	12	5	7	4	6	8	10
2024/2025	311	13	14	10	20	31	25	21	24	32	36	37	48
2025/2026	543	38	47	76	34	43	23	57	27	70	46	37	45
2026/2027	289	46	38	112	93	0	0	0	0	0	0	0	0
Totale													1.450